| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.001 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.001 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |